身材不成比例矮小患者初次全髋关节置换术围手术期结果与并发症的匹配队列分析
本研究基于机构数据库回顾2012至2017年初次全髋关节置换术患者,将108例身高低于148 cm者按年龄、性别和体重指数1:1匹配对照,最终分析矮身材组47例和对照组57例。结果显示矮身材组手术时间显著更长(133±65分钟 vs 104±30分钟,P=.005),住院时间稍长(3.2±1.5天 vs 2.6±1.0天,P=.017),但术中骨折、轻微并发症、90天再入院和翻修率相似。
要点
- 矮身材患者全髋置换手术时间显著延长(133±65分钟 vs 104±30分钟,P=.005)。
- 矮身材患者住院时间稍长(3.2±1.5天 vs 2.6±1.0天,P=.017)。
- 术中骨折、轻微并发症、90天再入院和翻修率与对照相似。
核心结论
- 身材不成比例矮小患者初次全髋关节置换术后手术时间和住院时间更长,但并发症和再入院率与匹配对照相似。
研究设计与样本
- 回顾性匹配队列分析,使用机构数据库纳入2012至2017年初次全髋关节置换术患者12,850例,其中108例身高低于148 cm。
- 矮身材组与对照组按年龄(P=.527)、性别(P=.664)和体重指数(P=.240)1:1匹配,最终分析纳入矮身材组47例和对照组57例,随访至少1年。
主要发现
- 矮身材组手术时间显著长于匹配对照组(133±65分钟 vs 104±30分钟,P=.005)。
- 矮身材组住院时间稍长于匹配对照组(3.2±1.5天 vs 2.6±1.0天,P=.017)。
- 术中骨折(P=1.000)、轻微并发症(P=.406)、90天再入院(P=.5000)和翻修(P=.202)率在两组间相似。
关键数值与推荐
- 矮身材定义为身高低于148 cm。
- 匹配变量为年龄、性别和体重指数,匹配后P值分别为.527、.664和.240。
- 手术时间差异P=.005,住院时间差异P=.017,术中骨折P=1.000,轻微并发症P=.406,90天再入院P=.5000,翻修P=.202。
临床怎么用
- 对身材不成比例矮小患者行初次全髋关节置换术时,应预期手术时间和住院时间可能延长。
- 尽管手术时间延长,矮身材患者并发症和再入院风险与匹配对照相似,可据此进行围手术期咨询。
局限性
- 最终分析样本量较小(矮身材组47例,对照组57例),作者呼吁未来更大样本研究确认 findings 并评估假体生存率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compared (1) perioperative outcomes, (2) postoperative complications, and (3) reoperation rates after primary total hip arthroplasty (THA) between short stature patients and matched control patients. METHODS: A review of primary THA patients from 2012 to 2017 using an institutional database was conducted. This yielded 12,850 patients of which 108 were shorter than 148 cm. These patients were matched 1:1 by age (P = .527), gender (P = .664), and body mass index (P = .240) to controls. The final study population with minimum 1-year follow-up that was included for analysis comprised 47 patients in the short stature cohort and 57 patients in the control cohort. The following outcomes/complications were compared: operative times, lengths of stay (LOSs), intraoperative fractures, minor complications, 90-day readmissions, and revisions. RESULTS: Operative times were significantly longer in the short stature cohort than in the matched control cohort (133 ± 65 minutes vs 104 ± 30 minutes, P = .005). In addition, hospital LOS was slightly longer in the short stature group than in the matched control groups (3.2 ± 1.5 days vs 2.6 ± 1.0, P = .017). Rates of intraoperative fractures (P = 1.000), minor complications P = .406), 90-day readmissions (P = .5000), and revision (P = .202) were similar between the short stature and control cohorts. CONCLUSION: Patients with disproportionately short stature had longer operative times and slight longer LOS. However, complication and readmission rates were similar. Future studies with larger sample sizes are warranted to confirm these findings and further evaluate implant survivorship in this unique THA patient population.
引用
- Anis HK, McConaghy KM, Charles RJ, et al. Perioperative Outcomes and Complications After Primary Total Hip Arthroplasty in Patients With Disproportionately Short Stature: A Matched Cohort Analysis. J Arthroplasty. 2019. PMID: 31678016. doi:10.1016/j.arth.2019.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。